We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+6.2%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.56B
AUM Growth
+$531M
Cap. Flow
+$49.6M
Cap. Flow %
0.52%
Top 10 Hldgs %
14.04%
Holding
1,755
New
15
Increased
420
Reduced
1,119
Closed
198

Top Sells

Rank Stock Value
1
DOC icon
Healthpeak Properties
DOC
+$48.2M
2
CLC
Clarcor
CLC
+$15.4M
3
AMGN icon
Amgen
AMGN
+$11.3M
4
AAPL icon
Apple
AAPL
+$9.79M
5
NUE icon
Nucor
NUE
+$8.91M

Sector Composition

Rank Sector Weight
1 Financials 15.52%
2 Healthcare 14.53%
3 Technology 12.08%
4 Consumer Staples 11.47%
5 Industrials 10.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLR
1151
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$366K ﹤0.01%
8,062
+471
+6% +$22.2K
WAGE
1152
DELISTED
WageWorks, Inc.
WAGE
$366K ﹤0.01%
5,063
-1,617
-24% -$120K
ARDX icon
1153
Ardelyx
ARDX
$1.24B
$365K ﹤0.01%
28,855
-7,410
-20% -$97.5K
TPH
1154
DELISTED
Tri Pointe Homes
TPH
$365K ﹤0.01%
29,096
-8,829
-23% -$108K
GRA
1155
DELISTED
W.R. Grace & Co.
GRA
$365K ﹤0.01%
5,242
-131
-2% -$9.2K
ACHN
1156
DELISTED
Achillion Pharmaceuticals
ACHN
$364K ﹤0.01%
86,462
-22,657
-21% -$94.1K
LYV icon
1157
Live Nation Entertainment
LYV
$41.2B
$362K ﹤0.01%
11,931
-1,841
-13% -$52.7K
ONC
1158
BeOne Medicines Ltd
ONC
$33.8B
$361K ﹤0.01%
9,872
+2,918
+42% +$106K
ANIP icon
1159
ANI Pharmaceuticals
ANIP
$1.77B
$360K ﹤0.01%
7,278
-1,822
-20% -$102K
NYT icon
1160
New York Times
NYT
$11.6B
$360K ﹤0.01%
25,018
-7,287
-23% -$104K
HE icon
1161
Hawaiian Electric Industries
HE
$2.33B
$359K ﹤0.01%
10,772
-1,513
-12% -$50.2K
JBTM
1162
JBT Marel
JBTM
$7.14B
$359K ﹤0.01%
4,087
-1,241
-23% -$108K
BCPC
1163
Balchem Corp
BCPC
$5.23B
$359K ﹤0.01%
4,361
-1,400
-24% -$118K
B
1164
DELISTED
Barnes Group Inc.
B
$357K ﹤0.01%
6,952
-2,235
-24% -$109K
DDD icon
1165
3D Systems Corp
DDD
$420M
$356K ﹤0.01%
23,800
-5,977
-20% -$93.8K
VG
1166
DELISTED
Vonage Holdings Corporation
VG
$355K ﹤0.01%
56,201
-22,171
-28% -$148K
CVBF icon
1167
CVB Financial
CVBF
$3.98B
$354K ﹤0.01%
16,039
-3,973
-20% -$90.8K
RICE
1168
DELISTED
Rice Energy Inc.
RICE
$354K ﹤0.01%
14,953
+1,084
+8% +$22.5K
WEX icon
1169
WEX
WEX
$6.11B
$353K ﹤0.01%
3,406
-486
-12% -$54K
BECN
1170
DELISTED
Beacon Roofing Supply, Inc.
BECN
$353K ﹤0.01%
7,181
-2,725
-28% -$126K
FCN icon
1171
FTI Consulting
FCN
$4.82B
$352K ﹤0.01%
8,542
-2,538
-23% -$105K
IART icon
1172
Integra LifeSciences
IART
$1.54B
$352K ﹤0.01%
8,350
-2,692
-24% -$115K
NXST icon
1173
Nexstar Media Group
NXST
$5.6B
$351K ﹤0.01%
5,002
+207
+4% +$13.9K
DAR icon
1174
Darling Ingredients
DAR
$9.93B
$349K ﹤0.01%
24,058
-7,394
-24% -$97.4K
INVX
1175
Innovex International
INVX
$1.87B
$349K ﹤0.01%
6,389
-208
-3% -$12.4K

Similar funds

ProShare Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, ProShare Advisors held 1,755 positions worth $9.56B, up 5.9% from $9.03B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

ProShare Advisors's Q1 2017 filing shows 15 new, 420 increased, 1,119 reduced and 198 closed positions. Its largest new stake was Qiagen: 113,675 shares worth $3.49M. The largest sale was Healthpeak Properties, an estimated $48.2M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • ProShare Advisors's largest Q1 2017 buy was Qiagen: 113,675 shares worth $3.49M.
  • ProShare Advisors added most to General Dynamics in Q1 2017, an estimated $57.1M increase.
  • ProShare Advisors's biggest Q1 2017 reduction was Healthpeak Properties, cutting an estimated $48.2M.
  • ProShare Advisors fully exited Clarcor in Q1 2017, selling an estimated $15.4M.
  • ProShare Advisors's ten largest holdings make up 14% of its $9.56B portfolio in Q1 2017.
  • ProShare Advisors opened 15 new positions and closed 198 in Q1 2017.
  • ProShare Advisors's portfolio value rose 5.9% quarter-over-quarter to $9.56B.

Based on ProShare Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.